Quality of life and outcomes in patients with a large toxic adenoma undergoing laser ablation plus radioiodine vs lobectomy

Figures & data

Table 1. Characteristics of patients.

Characteristics of patients	Group A (LA + RAI) [14]	Group B (surgery) [13]	P
M/F	4/10	5/8	ns
Age (yr)	63.5 ± 6	59.2 ± 12	ns
Uni/Multinodular	9/5	8/5	ns
TSH (mIU/L)	<0.01	<0.01	ns
FT4 (ng/dL)	2.7 ± 1	2.8 ± 1	ns
Thyroglobulin (ng/mL)	151.4 ± 85	126.8 ± 44	ns
Nodules volume (ml)	31 ± 4	31.5 ± 7	ns

Figure 1. Representative images of: baseline 99mTc thyroid scintiscan (A); ultrasound scan of toxic nodule before laser ablation (B); ultrasound scan 6 months after laser ablation (C); ultrasound scan 6 months after radioactive treatment and 12 months after laser ablation (D).

Figure 2. Health-related quality of life scores before and after treatment.

Døssing H, Bennedbaek FN, Bonnema SJ, et al. Randomized prospective study comparing a single radioiodine dose and a single laser therapy session in autonomously functioning thyroid nodules. Eur J Endocrinol. 2007;157:95–100.

 PubMed Web of Science ®Google Scholar

Pacella CM, Mauri G, Achille G, et al. Outcomes and risk factors for complications of laser ablation for thyroid nodules: a multicenter study on 1531 patients. J Clin Endocrinol Metab. 2015;100:3903–3910.

 PubMed Web of Science ®Google Scholar